Biotech Growth Ord (LSE:BIOG) - Investment trust price - Overview

Investment Trust Report

  • PDF
  • Analyst Research
  • Glossary

The Biotech Growth Trust PLC BIOG

Closing Price

1 Day Change

As of 21/08/2017

Last Close779.50
52-Wk Range627.75 - 822.50
Tot Assets Mil516.06
Mkt Cap Mil435.27
Yield %0.00
Estimated Nav829.59
Discount % %-6.04
12M Avg Disc %-6.22
Last Actual NAV830.86
Last NAV Date17/08/2017

Share Price Performance (GBP)

Key Statistics (GBP)
Total Assets516.063m
Net Assets463.245m
Market Capitalisation435.273m
Gross Gearing104%
Net Gearing112%
Average Daily Shares Traded (1 Yr)0.086m
Average Daily Value Traded (1 Yr)0.618m
Ongoing Charge (2017)1.10%
Legal StructureClosed End Fund
Traded CurrencyGBP
Launch Date23 Jun 1997
Financial Year EndMar 2018
Next AGMJul 2018
NAV FrequencyDaily
Dividend FrequencyAnnual
Valuation Statistics
 21/08/20171 Yr High1 Yr Low
Category Discount-1.510.66-8.45
Z-Statistics (1Yr)0.09  

Total Returns (GBP) 21/08/2017

 Chg (%)  
More ...
Cat Price-3.11
Cat NAV-4.14
Latest Dividends
TypeDividendEx-Dividend DateFinancial Year
Director Dealings
26/05/2017PurchaseMr. Steve Bates715.0010,00071,500.00

Morningstar Analyst Rating™


Morningstar Rating™

4 Stars

Morningstar® Category

Sector Equity Biotechnology


Fund Benchmark

Nasdaq Biotech Index

Morningstar® Benchmark

Fund Structure
Share Type# of Shares
Ordinary Share55.840m

Investment Objective

To achieve capital appreciation through investment in the worldwide biotechnology industry.
Richard Klemm19/05/2005
Geoffrey Hsu19/05/2005


Sven Borho, Dame Davies, Paul Gaunt, John Gordon, Andrew Joy, Peter Keen, John R Sclater
Fund prices are updated every weekday after the close of trading and before 11 p.m. wherever possible. All figures are as at Last Close, on a cum income basis with debt valued at fair and in traded currency unless otherwise stated (we do not fair value debt for split capital trusts). Performance returns are presented in British Pounds (GBP) and calculated on a capital only basis with debt valued at par.
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.